Parkin reinvents itself to regulate fatty acid metabolism by tagging CD36

Journal of Clinical Investigation

Volumn 121, Issue 9, 2011, Pages 3389-3392

  Abumrad, Nada A ^a   Moore, Darren J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ARACHIDONIC ACID; CALCIUM CHANNEL; CD36 ANTIGEN; COLLAGEN; OMEGA 3 FATTY ACID; PARKIN; PHOSPHOLIPASE A2; THROMBOSPONDIN 1; UBIQUITIN PROTEIN LIGASE;

CELL MEMBRANE; DIETARY INTAKE; DOPAMINERGIC NERVE CELL; FATTY ACID METABOLISM; GENE MUTATION; HUMAN; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NOTE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; UBIQUITINATION;

ANIMALS; DIETARY FATS; HUMANS; LIPID METABOLISM; MALE; UBIQUITIN-PROTEIN LIGASES;

EID: 80052381103     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI59219     Document Type: Note

References (25)

1. Gasser T. Mendelian forms of Parkinson's disease. Biochim Biophys Acta. 2009;1792(7):587-596.
2. Wirdefeldt K., Adami H.O., Cole P., Trichopoulos D., Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011;26(suppl 1):S1-S58.
3. Kitada T., et al. Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605-608. (Pubitemid 28207717)
4. West A.B., Maidment N.T. Genetics of Parkin-linked disease. Hum Genet. 2004;114(4):327-336. (Pubitemid 38324945)
5. Moore D.J. Parkin: A multifaceted ubiquitin ligase. Biochem Soc Trans. 2006;34(pt 5):749-753. (Pubitemid 44796412)
6. Moore D.J., West A.B., Dikeman D.A., Dawson V.L., Dawson T.M. Parkin mediates the degradation-independent ubiquitination of Hsp70. J Neurochem. 2008;105(5):1806-1819. (Pubitemid 351678490)
7. Kim K-Y, et al. Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells. J Clin Invest. 2011;121(9):3701-3712.
8. Chan N.C., et al. Broad activation of the ubiquitinproteasome system by Parkin is critical for mitophagy. Hum Mol Genet. 2011;20(9):1726-1737.
9. Silverstein R.L., Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal. 2009;2(72):re3.
10. Su X., Abumrad N.A. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol Metab. 2009;20(2):72-77.
11. Hajri T., Han X.X., Bonen A., Abumrad N.A. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest. 2002;109(10):1381-1389. (Pubitemid 34546903)
12. Yamashita S., et al. Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. Mol Cell Biochem. 2007;299(1-2):19-22. (Pubitemid 46767534)
13. Love-Gregory L., et al. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum Mol Genet. 2011; 20(1):193-201.
14. Ghosh A., et al. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms. Blood. 2011;117(23):6355-6366.
15. Lepretre F., et al. A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes. Hum Mutat. 2004;24(1):104.
16. Bousquet M., Calon F., Cicchetti F. Impact of omega- 3 fatty acids in Parkinson's disease [published online ahead of print March 23, 2011]. Ageing Res Rev. doi:10.1016/j.arr.2011.03.001.
17. De Lau L.M., Bornebroek M., Witteman J.C., Hofman A., Koudstaal P.J., Breteler M.M. Dietary fatty acids and the risk of Parkinson disease: The Rotterdam study. Neurology. 2005;64(12):2040-2045. (Pubitemid 40880989)
18. Farooqui T., Farooqui AA. Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Parkinsons Dis. 2011;2011:247467.
19. Greene J.C., Whitworth A.J., Kuo I., Andrews L.A., Feany M.B., Pallanck L.J. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila Parkin mutants. Proc Natl Acad Sci U S A. 2003; 100(7):4078-4083. (Pubitemid 36418160)
20. Smith B.K., et al. FAT/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation. Biochem J. 2011;437(1):125-134.
21. Miyake Y., et al. Dietary fat intake and risk of Parkinson's disease: a case-control study in Japan. J Neurol Sci. 2010;288(1-2):117-122.
22. Farooqui A.A., Horrocks L.A., Farooqui T. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide. J Neurosci Res. 2007; 85(9):1834-1850. (Pubitemid 47051473)
23. Darios F., Ruiperez V., Lopez I., Villanueva J., Gutierrez L.M., Davletov B. Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep. 2011;11(7):528-533.
24. Kuda O., et al. CD36 Protein Is Involved in Storeoperated Calcium Flux, Phospholipase A2 Activation, and Production of Prostaglandin E2. J Biol Chem. 2011;286(20):17785-17795.
25. Su X., Federoff H.J., Maguire-Zeiss K.A. Mutant alphasynuclein overexpression mediates early proinflammatory activity. Neurotox Res. 2009;16(3):238-254.